Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

The Top 10 Challenges Facing Laboratories Today

Navigating the Laboratory Automation Landscape

Save the dates: ZEISS Quality Innovation Summit, October 22-24

Embark on a journey to the future of metrology.

EU Pharmaceutical Legislation Reform

with stricter clinical trial regulations and pharmacovigilance. The reform accelerates access to innovative medicines through streamlined approvals, promotes competition by facilitating the entry of generics, and fosters collaboration among stakeholders. Additionally...

The Covid pandemic accelerated the development of cancer vaccine

The Covid pandemic gave a major boost to the vaccine field. The Danish biotech company Expres2ion Biotechnologies, which is developing a vaccine against breast ...

”Information security must become part of the Swedish life science strategy”

Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

Ny miljonsatsning på life science i Sverige

7,7 miljoner kronor ska nu satsas på ett projekt för att underlätta identifiering och produktion av läkemedel. Bridge Sweden är namnet på projektet och är ett s...

From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

Rise and Scantox cease conducting animal testing in Stockholm

Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...

Pharma Outsourcing – Find the Right Partner (2026)

Bio Europe intar Stockholm i höst – ”Det svenska ekosystemet tar nu tillfället i akt”

Den internationella life science-konferensen Bio Europe kommer i november för första gången till Sverige. Konferensen, vars program tar inspiration av ABBA-låta...

Sustainability at Festo

On the Way to the Net Zero Era - New Sustainability Report published

ZEISS Metrology Shop provides planning security

ZEISS Metrology Shop brings it all together.

Tougher competition as the Novo Nordisk Foundation broadens its programme

Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...

Misstänkt koppling mellan Ozempic och ögonsjukdom – myndighet reagerar

Två nya danska studier har pekat på en koppling mellan Ozempic (semaglutid) och en möjlig risk för den sällsynta ögonsjukdomen NAION. Nu vill danska läkemedelsv...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Clean solutions - Handling viscose substances with precision

Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...

Novo Nordisk gör AI-satsning inom kardiovaskulära sjukdomar

Novo Nordisk förvärvar rättigheterna till ett flertal prekliniska program från amerikanska Valo, ett företag med expertis inom AI-driven läkemedelsutveckling.

Svensk vaccinutvecklare får 24 miljoner av brittiskt forskningsprogram

Abera Bioscience får upp till motsvarande cirka 24 miljoner kronor i finansiering från ett brittiskt program inriktat på vacciner som ska stoppa epidemier i låg...

The Swedish Academy of Sciences: “We have too many researchers”

Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.

Cost-efficient development of laboratory devices

8 ways to optimise development costs and speed up processes

Amorphous materials take centre stage when Orexo develops new formulations

Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...

Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”

”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...